
Relative survival after diagnosis with a primary brain or other central nervous system tumor in the National Program of Cancer Registries, 2004 to 2014
Author(s) -
Quinn T. Ostrom,
Gabrielle Truitt,
Haley Gittleman,
Daniel J. Brat,
Carol Kruchko,
Reda Wilson,
Jill S. BarnholtzSloan
Publication year - 2019
Publication title -
neuro-oncology practice
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.666
H-Index - 14
eISSN - 2054-2585
pISSN - 2054-2577
DOI - 10.1093/nop/npz059
Subject(s) - central nervous system , brain cancer , medicine , cancer , oncology , primary cancer , relative survival , primary (astronomy) , brain tumor , pathology , cancer registry , physics , astronomy
The majority of reported cancer survival statistics in the United States are generated using the National Cancer Institute's publicly available Surveillance, Epidemiology, and End Results (SEER) data, which prior to 2019 represented 28% of the US population (now 37%). In the case of rare cancers or special subpopulations, data sets based on a larger portion of the US population may contribute new insights into these low-incidence cancers. The purpose of this study is to characterize the histology-specific survival patterns for all primary malignant and nonmalignant primary brain tumors in the United States using the Centers for Disease Control and Prevention's National Program of Cancer Registries (NPCR).